Evidence map›Paper›PMID 27646277›Full record

ArticleThe Journal of cell biology2016

Defective fluid shear stress mechanotransduction mediates hereditary hemorrhagic telangiectasia.

Nicolas Baeyens, Bruno Larrivée, Roxana Ola, Brielle Hayward-Piatkowskyi, Alexandre Dubrac, Billy Huang, Tyler D Ross, Brian G Coon, Elizabeth Min, Maya Tsarfati and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 180 citations in OpenAlex.

  1. Article
  2. Article
  3. Polycomb Repressive Complex 2 drives flow-sensitive endothelial states underlying vascular inflammation and disease.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Gene-Specific Endothelial Programs Drive AVM Pathogenesis inArteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Fluid Shear Stress-Regulated Vascular Remodeling: Past, Present, and Future.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Hereditary haemorrhagic telangiectasia.Nature reviews. Disease primers · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 4 countries.

Nicolas BaeyensDepartment of Medicine (Cardiology), Yale University School of Medicine, New Haven, CT 06511 Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT 06511.
Bruno LarrivéeDepartment of Medicine (Cardiology), Yale University School of Medicine, New Haven, CT 06511 Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT 06511 Department of Ophthalmology, Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, Quebec H3T 1J4, Canada.
Roxana OlaDepartment of Medicine (Cardiology), Yale University School of Medicine, New Haven, CT 06511 Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT 06511.
Brielle Hayward-PiatkowskyiDepartment of Medicine (Cardiology), Yale University School of Medicine, New Haven, CT 06511 Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT 06511.
Alexandre DubracDepartment of Medicine (Cardiology), Yale University School of Medicine, New Haven, CT 06511 Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT 06511.
Billy HuangDepartment of Medicine (Cardiology), Yale University School of Medicine, New Haven, CT 06511 Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT 06511.
Tyler D RossDepartment of Medicine (Cardiology), Yale University School of Medicine, New Haven, CT 06511 Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT 06511.
Brian G CoonDepartment of Medicine (Cardiology), Yale University School of Medicine, New Haven, CT 06511 Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT 06511.
Elizabeth MinDepartment of Medicine (Cardiology), Yale University School of Medicine, New Haven, CT 06511 Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT 06511.
Maya TsarfatiDepartment of Medicine (Cardiology), Yale University School of Medicine, New Haven, CT 06511 Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT 06511.
Haibin TongDepartment of Medicine (Cardiology), Yale University School of Medicine, New Haven, CT 06511 Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT 06511 Jilin Provincial Key Laboratory of Molecular Geriatric Medicine, Life Science Research Center, Beihua University, Jilin 132013, China.
Anne EichmannDepartment of Medicine (Cardiology), Yale University School of Medicine, New Haven, CT 06511 Institut National de la Santé et de la Recherche Médicale U970, Paris Center for Cardiovascular Research, 75015 Paris, France.
Martin A SchwartzDepartment of Medicine (Cardiology), Yale University School of Medicine, New Haven, CT 06511 Department of Cell Biology, Yale University, New Haven, CT 06510 Department of Biomedical Engineering, Yale University, New Haven, CT 06510 martin.schwartz@yale.edu.
Yale University · USBeihua University · CNHôpital Maisonneuve-Rosemont · CA

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Surgery / Physiology CoreP01HL107205 · NHLBI · YALE UNIVERSITY · PI SIMONS, MICHAEL · 2012 to 2022
$18.8M
Vascular Training GrantT32HL007950 · NHLBI · YALE UNIVERSITY · PI JEFFREY R. BENDER, Daniel Greif · 2000 to 2026
$9.6M
GENETICS AND GENOMICS OF HUMAN DISEASET32HD007149 · NICHD · YALE UNIVERSITY · PI James P Noonan · 1985 to 2026
$8.2M
Integrins in the Endothelial Response to Fluid Shear StressR01HL075092 · NHLBI · YALE UNIVERSITY · PI SCHWARTZ, MARTIN A · 2004 to 2019
$5.1M
Targeting endothelial migration to prevent neovascularizationR01HL125811 · NHLBI · YALE UNIVERSITY · PI EICHMANN, ANNE CHRISTINE · 2015 to 2025
$4.1M
Novel approaches to manipulate sprouting angiogenesisR01EY025979 · NEI · YALE UNIVERSITY · PI EICHMANN, ANNE CHRISTINE · 2015 to 2019
$1.9M
NCATS NIH HHS UL1 TR001863NEI NIH HHS R01 EY025979NHLBI NIH HHS P01 HL107205NHLBI NIH HHS R01 HL075092NHLBI NIH HHS R01 HL125811NHLBI NIH HHS T32 HL007950NICHD NIH HHS T32 HD007149
6 · The paper itself

Abstract

Morphogenesis of the vascular system is strongly modulated by mechanical forces from blood flow. Hereditary hemorrhagic telangiectasia (HHT) is an inherited autosomal-dominant disease in which arteriovenous malformations and telangiectasias accumulate with age. Most cases are linked to heterozygous mutations in Alk1 or Endoglin, receptors for bone morphogenetic proteins (BMPs) 9 and 10. Evidence suggests that a second hit results in clonal expansion of endothelial cells to form lesions with poor mural cell coverage that spontaneously rupture and bleed. We now report that fluid shear stress potentiates BMPs to activate Alk1 signaling, which correlates with enhanced association of Alk1 and endoglin. Alk1 is required for BMP9 and flow responses, whereas endoglin is only required for enhancement by flow. This pathway mediates both inhibition of endothelial proliferation and recruitment of mural cells; thus, its loss blocks flow-induced vascular stabilization. Identification of Alk1 signaling as a convergence point for flow and soluble ligands provides a molecular mechanism for development of HHT lesions.

Indexed as

Mechanotransduction, CellularStress, MechanicalActivin Receptors, Type IIArteriovenous MalformationsArteriovenous Shunt, SurgicalBone Morphogenetic ProteinsCell ProliferationEndoglinEndothelial CellsGene DeletionHEK293 CellsHemorheologyHumansHuman Umbilical Vein Endothelial CellsPericytesRegional Blood FlowActivin Receptors, Type IIACVRL1 protein, humanBone Morphogenetic ProteinsEndoglin

Identifiers

PMID27646277
PMCPMC5037412
OpenAlexW2523446095

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.